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The essential oil from leaves of Annona foetida obtained by hydrodistillation was analyzed by GC/FID and GC/MS. The results 
showed that the major constituents were bicyclogermacrene (35.12%), (E)-caryophyllene (14.19%) and α-copaene (8.19%). The 
antimicrobial and antileishmanial activities were investigated. The oil showed potent antimicrobial activity against Candida albicans 
and Rhodococcus equi. The oil also showed significant antileishmanial activity, giving the best results against Leishmania guyanensis. 
A preliminary cytotoxicity assay for this oil was carried out on hamster and mice (Balb/c) peritoneal macrophages. The results 
obtained were similar to pentamidine and considered not to be cytotoxic to macrophages.
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introdUction
The Annonaceae is a large family of tropical and subtropical trees 
and shrubs, comprising about 135 genera and more than 2500 species.1 
This family is known for the edible fruits2 and medicinal properties of 
many species.3 Previous chemical and pharmacological investigations 
on some species of this family have indicated the presence of important 
bioactive compounds, exhibiting various pharmacological activities 
including antimicrobial,4,5 insecticidal4,5 and antiparasitic properties, in 
particular against Leishmania sp.,6-10 Plasmodium falciparum11,12 and 
Trypanosoma cruzi.7,8,10 These activities are attributed to aporphine4,8 
and β-carboline6 alkaloids, lactones,9 acetogenins10 and essential oils.12 
Among several species of Annonaceae with antiparasitic activity is 
Annona foetida Martius. This species, commonly known as “araticum 
caatinga”, “envira-ata” or “graviola do mato,” is a tropical tree found in 
the Brazilian and Peruvian Amazon region.3,13 Besides the antileishma-
nial activity demonstrated by the extracts, fractions and pure compounds 
isolated from this source,6 this species is also reportedly used in folk 
medicine in the Brazilian northeast against rheumatism, intermittent 
fevers and ulcers, particularly the leaves and the bark.3
In previous studies on this species, aporphine and β-carboline 
alkaloids with antileishmanial activity were isolated.6 In continuation 
of our studies on A. foetida in a search for novel antileishmanial and 
antimicrobial natural products, we now report the characterization 
of the essential oil from the leaves. This is the first report on the 




The leaves of A. foetida were collected at the Adolpho Ducke 
Reserve [coordinates: 02° 57’ 21’’ S 59° 55’ 20’’ W], near the city of 
Manaus, Amazonas, Brazil. The plant was identified by the Annon-
aceae specialist Dr. A. C. Webber from the Universidade Federal do 
Amazonas (UFAM). A voucher specimen (number 7275) is deposited 
at the Herbarium of UFAM, Manaus, Amazonas, Brazil.
extraction of essential oil
The leaves (200 g) of A. foetida were dried at room temperature 
for 3 days and submitted to hydrodistillation for 4 h, in a Clevenger-
type apparatus. The oil was dried over anhydrous sodium sulphate, and 
the percentage content was calculated on the basis of the dry weight 
of plant material. The oil was stored at 4 °C for further analysis. The 
extraction of essential oil was performed in triplicate.
chemical analyses
GC/FID
The analyses of the volatile compounds were carried out on a 
Varian 3800 GC system with a fused capillary column (30 m x 0.25 
mm x 0.25 µm, VA-5 Crossbond 5% phenyl-95% dimethylpolysilox-
ane, Sigma-Aldrich) directly coupled to a flame ionization detector. 
Conditions of injection were modified from Adams:14 injector tem-
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perature 240 oC; oven temperature program of 60-300 oC at a rate of 
3 oC/min; split 20:1 during 1.50 min, carrier gas He: 1.0 mL min-1, 
constant flow; sample volume 1 µL. 
GC/MS
The analyses were performed using the EI mode on a Varian 3800 
GC system with a fused capillary column (30 m x 0.25 mm x 0.25 
mm, VF-5MS, Crossbond 5% phenyl - 95% dimethylpolysiloxane) 
directly coupled to a Varian Saturn 2000 selective mass detector. 
The conditions of injection were the same as described above. The 
mass spectrometer was operated at 70 eV. Retention indices (RI) 
were determined by co-injection of hydrocarbon standards.15 The 
oil components were identified by comparison with data from the 
literature14 and the profiles from the NIST-05 library.
Antimicrobial assay
The growth inhibitory activity of the essential oil was tested 
against 11 microorganisms (Bacillus subtilis ATCC 5061, Candida 
albicans ATCC 10231, Enterococcus faecium CCT 5079, Enterococ-
cus hirae ATCC 10541, Escherichia coli ATCC 11775, Micrococcus 
luteus ATCC 4698, Pseudomonas aeruginosa ATCC 13388, Rho-
dococcus equi ATCC 6939, Salmonella choleraesuis ATCC 10708, 
Staphylococcus aureus ATCC 6538 and Staphylococcus epidermides 
ATCC 12228). 
The bacteria strains were cultured overnight at 36 oC in Nutrient 
Agar (Merck), while C. albicans was cultured in Saboraud Dextrose 
Agar. Inoculum for the assays was prepared by diluting a scraped cell 
mass in 0.85% NaCl solution, adjusted to McFarland scale 0.5 and 
confirmed by spectrophotometer reading at 580 nm. Cell suspensions 
were finally diluted to 104 CFU mL-1 for use in the activity assays. 
MIC (Minimal Inhibitory Concentration) tests were carried out ac-
cording to Eloff,16 using Müller-Hinton broth on a tissue-culture test 
plate (96 wells). The stock solution of essential oil was diluted and 
transferred into the first well, and serial dilutions were made so that 
concentrations in the range of 1.0-0.015 mg mL-1 were obtained. 
Chloramphenicol and nystatin (Merck) were used as the reference 
antibiotic control in the range of 0.25-0.002 mg mL-1. The inoculum 
was added to all wells, and the plates were incubated at 36 oC for 48 h. 
Each concentration was screened in triplicate. Antimicrobial activity 
was detected by adding 20 µL of 0.5% TTC (triphenyl tetrazolium 
chloride, Merck) aqueous solution. MIC was defined as the lowest 
concentration of the essential oil that inhibited visible growth, as 
indicated by TCC staining (dead cells are not stained by TTC).
In vitro antileishmanial assay
Cultures of Leishmania amazonensis (MHOM/BR/77/LTB0016), 
L. braziliensis (MHOM/BR/95/IOCL-2033), L. chagasi (MCAN/
BR/97/P142) and L. guyanensis (MHOM/BR/95/IOCL-2092) pro-
mastigotes characterized by isoenzyme analysis were used for in 
vitro screening. Briefly, promastigotes were cultivated in Schneider’s 
Drosophila medium supplemented with 20% (v/v) heat-inactivated 
fetal calf serum (FCS) and harvested from the medium in the late-
log phase. The antileishmanial screening of the essential oil was 
performed in flat-bottomed plastic 96-well tissue plates maintained 
at 26 oC. Promastigote forms were suspended to yield 4.0 x 106 cells 
mL-1 after hemocytometer counting. Each well was filled with 100 
µL of the parasite suspension, and the plates were incubated at 26 
oC. The essential oil to be tested was dissolved in DMSO and then 
added to each well to obtain a final concentration of 0.16 µg mL-1. 
At up to 1.6% (v/v), DMSO had no effect on parasite growth. Each 
concentration range 160-0.16 µg mL-1 was screened in triplicate. The 
oil and pentamidine isethionate (reference drug) were added to the 
culture, and after 24 h the viability of the treated cells was compared 
to the control without drugs, through the MTT methodology.17,18 
cytotoxicity assay 
In order to evaluate the toxicity of the compound to the host cell, 
mice or hamster peritoneal macrophages were isolated in RPMI 1640 
medium (Sigma Cell Culture, St. Louis, Missouri, USA), containing 
200 UI mL-1 penicillin, 200 µg mL-1 streptomycin, 1 mM sodium 
pyruvate, 1 mM L-glutamine and 1 M HEPES buffer (Sigma Cell 
Culture, St. Louis, Missouri, USA). Cells were counted in a Neubauer 
chamber using Erythrosine B as a vital dye (Sigma Cell Culture, St. 
Louis, Missouri, USA), and adjusted to a concentration of 4.0 x106 
cell mL-1. After that, cells were cultured in a 96-well culture plate 
(Falcon, New Jersey, USA), at 37 °C and in an atmosphere of 5% CO
2. 
The sample was added to the medium in a concentration equivalent 
to IC
50
 and 2 x IC
50
 of the in-vitro activity assay from L. amazonensis 
and L. chagasi. The sample and pentamidine isethionate (reference 
drug) were added to the culture, and after 24 h the viability of treated 




Hydrodistillation of the leaves of A. foetida gave a yellowish 
crude essential oil, with a yield of 0.01% in relation to the dry weight 
of the plant material, and a density at 25 oC of 0.9055 g mL-1. As 
shown in Table 1, 34 compounds of the essential oil were identified 
by GC/FID and GC/MS analysis, comprising 93.06% of the oil. The 
results of the analyses showed that the oil is a complex mixture, 
consisting particularly of sesquiterpenes. The major components 
identified were bicyclogermacrene (35.12%), (E)-caryophyllene 
(14.19%), α-copaene (8.19%) and γ-cadinene (4.84%). Other con-
stituents identified in smaller quantities were viridiflorol (3.51%), 
cis-β-guaiene (3.47%), γ-muurolene (2.77%), α-humulene (2.22%), 
aromadendrene (1.81%), α-cubebene (1.60%), allo-aromadendrene 
(1.51%), spathulenol (1.11%), α-gurjunene (1.26%) and cyperene 
(1.23%). Monoterpenes were not detected in the oil. 
The presence of bicyclogermacrene, (E)-caryophyllene, 
γ-muurolene, α-humulene, spathulenol and β-elemene and the other 
compounds identified in our study has been reported in essential oils 
of many species of the familyAnnonaceae.19-22 Among these identified 
components, the oxygenated sesquiterpene spathulenol is considered 
as a chemotaxonomic marker of species of Annonaceae, because it 
has been identified in several species of this family belonging to the 
genera Annona, Artabotrys, Cleistopholis, Desmos, Duguetia, Fusae, 
Goniothalamus, Guatteria, Guatteriopsis, Hexalobus, Melodorum, 
Pachypodanthium, Piptostigma, Uvaria and Xylopia.12,19-22 (E)-
caryophyllene is frequently found in the species of Annona, and could 
be considered together with caryophyllene oxide as chemotaxonomic 
markers for this genus. 12,19-22 
Antimicrobial activity
The results obtained in the evaluation of the antimicrobial activity 
of the essential oil of A. foetida are shown in Table 2. The essential 
oil of A. foetida exhibited a significant antimicrobial activity against 
5 of the 11 microorganisms tested, showing strong activity against 
Candida albicans and Rhodococcus equi, both with MIC values of 60 
µg mL-1. For Micrococcus luteus, Bacillus subtilis and Staphylococcus 
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particularly for veterinary medicine. In Brazil this infection is one of 
the most severe diseases affecting colts and other young animals, cau-
sing high mortality even if the animals are treated with antimicrobial 
agents.23 This is the second report of medicinal plants belonging to 
Annonaceae that show antimicrobial activity against R. equi.22 
The significant antimicrobial activity of the essential oil from 
leaves of A. foetida may be attributed to the high sesquiterpene content 
(93.05%), along with minor terpenoid constituents. The co-occurrence 
of bicyclogermacrene and (E)-caryophyllene has been reported in 
antimicrobial essential oils24,25 and this activity is largely shown by 
essential oils containing (E)-caryophyllene.26,27 
Antileishmanial activity
The results of the evaluation of antileishmanial activity of the 
essential oil of A. foetida are shown in Table 3. This essential oil was 
active against all species of Leishmania tested. The best result was 
observed against L. guyanensis, with IC
50
 value of 4.1 µg mL-1. The 
results obtained against L. braziliensis, L. amazonensis and L. chagasi 
were, respectively, 9.9, 16.2 and 27.2 µg mL-1, IC
50
 values. 
The observed antileishmanial activity can probably be attribu-
ted to the mixture of sesquiterpene constituents, as observed for 
the antimicrobial activity. Several oxygenated sesquiterpenes have 
evidenced significant activity against Leishmania sp.28,29 but there is 
no scientific report on antileishmanial activity for unfunctionalized 
sesquiterpenes, and the mechanisms of action remain unclear. Recent 
studies on cultures of L. amazonensis promastigotes revealed that 
table 1. Chemical composition of essential oil from the leaves of 
Annona foetida
Constituents a RI b RI c %
δ-Elemene 1331 1338 0.27
α-Cubebene 1346 1351 1.60
Isoledene 1369 1376 0.13
α-Copaene 1375 1377 8.19
β-Bourbonene 1382 1388 0.50
β-Cubebene 1387 1388 0.91
β-Elemene 1389 1391 0.98
Cyperene 1401 1399 1.23
α-Gurjunene 1409 1410 1.26
(E)-Caryophyllene 1418 1419 14.19
β-Copaene 1429 1432 0.55
β-Gurjunene 1433 1434 0.21
Aromadendrene 1437 1441 1.81
cis-Muurola-3,5-diene 1448 1450 0.52
α-Humulene 1454 1455 2.22
Allo-Aromadendrene 1458 1460 1.51
trans-Cadina-1(6),4-diene 1472 1477 0.89
γ-Gurgenene 1475 1477 1.04
γ-Muurolene 1480 1480 2.77
δ-Selinene 1488 1493 0.42
cis-β-Guaiene 1491 1493 3.47
Bicyclogermacrene 1496 1500 35.12
α-Muurolene 1499 1500 0.21
trans-β-Guaiene 1507 1503 0.22
β-Himachalene 1513 1505 0.20
γ-Cadinene 1518 1512 4.84
δ-Cadinene 1523 1523 0.80
(E)-γ-Bisabolene 1528 1531 0.14
trans-Cadina-1(2),4-diene 1533 1535 0.54
Germacrene B 1558 1561 0.80
Spathulenol 1579 1578 1.11
Viridiflorol 1595 1593 3.51
1-epi-Cubenol 1630 1629 0.46
Cubenol 1645 1647 0.44
Compounds identified 93.06
Compounds not identified 6.94
Total 100
a Identification was based on comparison of their GC/MS spectra and RI 
with those of the internal (computer) NIST library and those described 
by Adams (2001)14. b RI was determined on VF-5MS on the basis of 
n-alkanes, and calculated according to the method of Van Den Dool 
and Kratz (1963) .15 c RI according to ref. 14







Bacillus subtilis ATCC 5061 600 20a
Candida albicans ATCC 10231 60 50b
Enterococcus faecium CCT 5079 - 70a
Enterococcus hirae ATCC 10541 - 120a
Escherichia coli ATCC 11775 - 40a
Micrococcus luteus ATCC 4698 200 50a
Pseudomonas aeruginosa ATCC 13388 - 850a
Rhodococcus equi ATCC 6939 60 40a
Salmonella choleraesuis ATCC 10708 - 60a
Staphylococcus aureus ATCC 6538 200 20a
Staphylococcus epidermides ATCC 12228 - 40a
(-) > 1000 µg mL-1. a Chloramphenicol. b Nystatin. ATCC (American 
Type Culture Collection). CCT (Tropical Culture Collection)
table 3. In vitro activity of essential oil of Annona foetida against 












Essential Oil 16.2 ±1.9 9.9 ±1.2 27.2 ±6.2 4.1 ±0.2
Pentami-
dine a
4.8 ±0.1 1.0 ±0.1 19.0 ±2.9 0.3 ±0.1
a Reference drug.
aureus, the essential oil showed activity with MIC values of 200, 600 
and 200 µg mL-1, respectively. The results obtained for the essential 
oil against C. albicans and R. equi were close to the results shown 
by the reference drugs, indicating that this oil is a natural source of 
biologically active compounds. The results observed against R. equi, a 
bacterium responsible for pneumonia in animals, are very promising, 
Antimicrobial and antileishmanial activity of essential oil 81Vol. 32, No. 1
the oxygenated sesquiterpene nerolidol possesses antileishmanial 
activity, which may be associated with inhibition of the biosynthesis 
of cellular isoprenoids.30 This encourages an intensive investigation 
of the mechanisms of action of terpene essential oils.
It has been also suggested that the low density of the essential oils 
and their ready diffusion across cell membranes contribute to enhance 
targeting intracellular protozoal malaria parasites.12 Nevertheless, 
further studies are required to explain the complete mechanisms of 
these interactions, particularly in the specific case of leishmaniasis. 
The oil was also tested for cytotoxicity, using hamster and mice 
(Balb/c) peritoneal macrophages (unparasitized cells), considering 
that the former is the animal model for L. chagasi, and the latter is 
the animal model for L. amazonensis (Table 4). The oil showed a 
low cytotoxicity to hamster peritoneal macrophages (less than 6%), 
while the reference drug pentamidine isethionate did not show any 
cytotoxicity. For Balb/c macrophages, the sample and the reference 
drug showed similarly low cytoxicity (less than 6%) and can be 
considered as not cytotoxic. 
conclUsion 
This is the first report on the analysis of the volatile constituents 
from leaves of A. foetida and its biological activities. The essential oil 
demonstrated significant antimicrobial and antileishmanial activities, 
and low cytotoxicity to hamster and mice (Balb/c) peritoneal macro-
phages, suggesting that this species is a rich source of biologically 
active compounds. The presence of spathulenol in this oil is very 
important for the chemotaxonomy of the family Annonaceae, because 
it has been found in almost all the genera of this family, particularly 
in Annona, Guatteria and Xylopia. The results obtained in this study 
confirm the importance of chemical and biological investigations of 
essential oils of annonaceous species in the search for new and safer 
antimicrobial and antileishmanial agents. 
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table 4. In vitro cytotoxicity assay of essential oil of Annona foetida 








Essential Oil (2 x IC
50
) 4.76 7.26
Pentamidine a 0.00 5.47
a Reference drug.
